Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04945174
Other study ID # H-20059985
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2022
Est. completion date December 2029

Study information

Verified date June 2022
Source Herlev Hospital
Contact Christina Kruuse, Professor
Phone +45 3868 1233
Email christina.kruuse@regionh.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In a randomized controlled trial the effect of 12 weeks of cross-sectorial physical exercise combined with patient education and individual follow-up session is investigated in patients with minor stroke or non-disabling stroke.


Description:

Hypertension and physical inactivity are the most common risk factors for stroke. Patients with minor stroke or transient ischemic attack (TIA) have short-lasting symptoms, often with remission within hours or days. Though patients experience a quick remission, they have an increased risk of a recurrent stroke and progressive cognitive dysfunction. The patients are also likely to have other disposing risk factors such as diabetes, smoking, and hypercholesterolemia which may increase the risk of a recurrent stroke. Following hospital discharge, the patients are offered preventive medication, but no standardized rehabilitation or exercise. Previous studies have shown that physical exercise decreases cardiovascular risk factors for patients after stroke and increases physical function and quality of life. The aim is to develop and evaluate a standardized exercise program (a stroke school) for patients with minor stroke or TIA. The intervention consist of 6 weeks of supervised aerobic exercise at the hospital combined with patient education including knowledge on stroke risk factors. Subsequently, 6 weeks of supervised aerobic exercise in their local municipality. After the 12 weeks of exercise, patients are offered individual, motivational follow-up sessions with the purpose to facilitate the patients to stay physically active in their everyday life. This intervention will increase the patients´ knowledge regarding risk factors for stroke and cardiovascular disease, increase their cardiorespiratory fitness and facilitate the patients to be physical active and hopefully slow the progression of vascular disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2029
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with a minor stroke or TIA without the need of rehabilitation after hospital discharge, but need physical activity in order to prevent cardiovascular diseases - Patients spending = 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months - Able to speak and read Danish and to provide informed consent - Individuals = 18 years of age Exclusion Criteria: - Previous large-artery stroke or hemorrhagic stroke - Unstable cardiac condition, e.g. pacemaker - Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines) - Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication) - Dyspnoea caused by heart or pulmonary disease (e.g. COPD) - Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations. - Patients diagnosed with dementia at hospital admission (a score =23/30 on the Mini-Mental State Examination are not invited into the study)

Study Design


Intervention

Behavioral:
Cardiorespiratory exercise combined with patient education and individual follow-up sessions
6 weeks of cardiorespiratory exercise combined with patient education at the hospital, followed by 6 weeks of cardiorespiratory exercise in the local municipality. Subsequently individual follow-up sessions with the aim to facilitate the patients to stay physically active in their everyday life

Locations

Country Name City State
Denmark Herlev Hospital Copenhagen Herlev
Denmark Department of Neurology, Herlev-Gentofte Hospital Herlev

Sponsors (1)

Lead Sponsor Collaborator
Herlev Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of patients with cardiovascular event from baseline to 5 years post-stroke Follow-up 5 years from inclusion on cardiovascular events 5 years post-stroke
Other Number of patients who have died from baseline to 5 years post-stroke Follow-up 5 years from inclusion on death 5 years post stroke
Primary Change in 'the Graded Cycling Test with Talk Test' from baseline to 3 months A sub-maximal exercise test on a stationary bicycle where the workload increases by 15 Watts (W) every minute and each minute the patient recites a standardized text passage. When the patient is no longer able to speak comfortably the test terminates. The higher score the better cardiorespiratory fitness from baseline to 3 months (post-intervention)
Secondary Change in Physical Activity Scale A questionnaire measuring number of hours of self-reported physical activity during daily living. It reveals daily time spent on sleep, sitting down at work, standing/walking at work, heavy physical work during working hours, active commuting to/from work, and sedentary behavior, including television watching and reading. Additionally, the patients record the weekly time spent on light-intensity, moderate-intensity, and vigorous-intensity activity during leisure time. from baseline to 3 months (post-intervention)
Secondary Change in Physical Activity Scale from baseline to 12-months post-stroke A questionnaire measuring number of hours of self-reported physical activity during daily living. It reveals daily time spent on sleep, sitting down at work, standing/walking at work, heavy physical work during working hours, active commuting to/from work, and sedentary behavior, including television watching and reading. Additionally, the patients record the weekly time spent on light-intensity, moderate-intensity, and vigorous-intensity activity during leisure time. From baseline to 12-months post-stroke
Secondary Change in maximum cardiopulmonary exercise test from baseline to 3 months post-stroke A maximal exercise test on a stationary bicycle from baseline to 3 months (post-intervention)
Secondary Change in The WHO-5 Well-being index from baseline to to 3 months post-stroke A questionnaire measuring current mental well-being on a scale from 0-100 points where higher points indicates better mental well-being from baseline to 3 months (post-intervention)
Secondary Change in The WHO-5 Well-being index from baseline to 12-months post-stroke A questionnaire measuring current mental well-being on a scale from 0-100 points where higher points indicates better mental well-being From baseline to 12-months post-stroke
Secondary Change in Montreal Cognitive Assessment from baseline to 3 months post-stroke A cognitive screening test for detection of mild cognitive impairments, the score ranges from 0-30 points and a high score indicates better cognitive function from baseline to 3 months (post-intervention)
Secondary Change in Montreal Cognitive Assessment from baseline to 12-months post-stroke A cognitive screening test for detection of mild cognitive impairments, the score ranges from 0-30 points and a high score indicates better cognitive function From baseline to 12-months post-stroke
Secondary Change in Beck Depression Inventory from baseline to 3 months post-stroke A self-report mood questionnaire. The total score ranges from 0-63 points, and a high total score indicates more severe depressive symptoms from baseline to 3 months (post-intervention)
Secondary Change in Beck Depression Inventory from baseline 12-months post-stroke A self-report mood questionnaire. The total score ranges from 0-63 points, and a high total score indicates more severe depressive symptoms From baseline 12-months post-stroke
Secondary Change in Fatigue Severity Scale from baseline to 3 months post-stroke A 20-item self-report instrument designed to measure fatigue. The score ranges from 9-63 points, and a higher score indicates greater severity of fatigue from baseline to 3 months (post-intervention)
Secondary Change in Fatigue Severity Scale from baseline to 12-months post-stroke A 20-item self-report instrument designed to measure fatigue. The score ranges from 9-63 points, and a higher score indicates greater severity of fatigue From baseline to 12-months post-stroke
Secondary Change in blood pressure from baseline to 3 months post-stroke Assessment of blood pressure (systolic and diastolic) from baseline to 3 months (post-intervention)
Secondary Change in blood pressure from baseline to 12-months post-stroke Assessment of blood pressure (systolic and diastolic) From baseline to 12-months post-stroke
Secondary Change in body mass index from baseline to 3 months post-stroke Measures of weight in kilograms, and height in meters will be aggregated to arrive at one reported value, the body mass index (kg/m^2). from baseline to 3 months (post-intervention)
Secondary Change in body mass index from baseline to 12-months post-stroke Measures of weight in kilograms, and height in meters will be aggregated to arrive at one reported value, the body mass index (kg/m^2). From baseline to 12-months post-stroke
Secondary Change in Modified rankin scale from baseline to 3 months post-stroke A measurement of symptoms/motor function. The score ranges from 0-6 points, where 0 represents "no symptoms at all" and 6 points represents "dead". from baseline to 3 months (post-intervention)
Secondary Change in Modified rankin scale from baseline to 12-months post-stroke A measurement of symptoms/motor function. The score ranges from 0-6 points, where 0 represents "no symptoms at all" and 6 points represents "dead". From baseline to 12-months post-stroke
Secondary Change in high-sensitivity C-reactive protein from baseline to 3 months post-stroke Blood samples to evaluate degree of inflammation (low risk: < 1 mg/L, average risk: 1-3 mg/L, and high risk: >3 mg/L). from baseline to 3 months (post-intervention)
Secondary Change in high-sensitivity C-reactive protein from baseline to 12-months post-stroke Blood samples to evaluate degree of inflammation (low risk: < 1 mg/L, average risk: 1-3 mg/L, and high risk: >3 mg/L). From baseline to 12-months post-stroke
Secondary Change in Pro brain natriuretic peptid from baseline to 3 months post-stroke Blood samples to evaluate cardiac function (normal: < 125 pg/mL, critical value: > 400 pg/mL) from baseline to 3 months (post-intervention)
Secondary Change in Pro brain natriuretic peptid from baseline to 12-months post-stroke Blood samples to evaluate cardiac function (normal: < 125 pg/mL, critical value: > 400 pg/mL) From baseline to 12-months post-stroke
Secondary Change in Cathepsin B from baseline to 3 months post-stroke Blood samples to evaluate muscle protein. (high level of Cathepsin B may associate to improve cognitive function) from baseline to 3 months (post-intervention)
Secondary Change in Cathepsin B from baseline to 12-months post-stroke Blood samples to evaluate muscle protein. (high level of Cathepsin B may associate to improve cognitive function) From baseline to 12-months post-stroke
Secondary Change in Magnetic Resonance Imaging from baseline to 12-months post-stroke detection of number of new infarcts or white matter lesions From baseline to 12-months post-stroke
Secondary Change in outcome expectancy for exercise-2 scale from baseline to 3 months post-stroke A questionnaire measuring self-efficacy for exercise. The total score consist of two subscales; a postive and a negative. The positive subscale ranges from 1-5, and a higher positive sub-score indicates stronger/more positive outcome expectations for exercise, and the negative subscale ranges from 1-4, and a higher negative sub-score indicates more negative outcome expectations for exercise. from baseline to 3 months (post-intervention)
Secondary Change in outcome expectancy for exercise-2 scale from baseline to 12-months post-stroke A questionnaire measuring self-efficacy for exercise. The total score consist of two subscales; a postive and a negative. The positive subscale ranges from 1-5, and a higher positive sub-score indicates stronger/more positive outcome expectations for exercise, and the negative subscale ranges from 1-4, and a higher negative sub-score indicates more negative outcome expectations for exercise. From baseline to 12-months post-stroke
Secondary Change in the Stages of exercise behavior change from baseline to 3 months post-stroke A questionnaire consisting of six categories describing differerent stages towards exercise behavior change, ranking from no intention to change behavior (precontemplation) to sustain behavior change (maintenance).
Data will be analysed by calculating the number of patients (percentage) in each category and with a comparison between groups
from baseline to 3 months (post-intervention)
Secondary Change in the Stages of exercise behavior change from baseline to 12-months post-stroke A questionnaire consisting of six categories describing differerent stages towards exercise behavior change, ranking from no intention to change behavior (precontemplation) to sustain behavior change (maintenance).
Data will be analysed by calculating the number of patients (percentage) in each category and with a comparison between groups
From baseline to 12-months post-stroke
See also
  Status Clinical Trial Phase
Recruiting NCT00859885 - International PFO Consortium N/A
Not yet recruiting NCT03605355 - Feasibility Study on the Medical and Economic Consequences of Outpatient Management of TIAs and Minor Strokes
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Completed NCT04078737 - Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II Phase 3
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT01954329 - Markers in the Diagnosis of TIA N/A
Completed NCT02011256 - Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack N/A
Completed NCT01918891 - Center for Stroke Disparities Solution - Community Transitions Intervention N/A
Recruiting NCT01526824 - Lovaza's Effect on Clopidogrel in a Neuro Population Phase 0
Completed NCT01020851 - The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial N/A
Completed NCT00597974 - Neurological Outcome With Carotid Artery Stenting N/A
Completed NCT00211731 - Preventing Recurrent Stroke in Minority Populations N/A
Active, not recruiting NCT03635749 - Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Phase 3
Completed NCT03153020 - Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône
Recruiting NCT04075500 - Optimal Detection of Atrial Fibrillation in TIA N/A
Recruiting NCT06091319 - Florbetaben for Imaging of Vascular Amyloid
Completed NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt N/A
Completed NCT00885456 - Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT Phase 2
Completed NCT05620966 - EEG to Diagnose TIA and Stroke